Takeda Pharmaceutical Company Limited Raw Materials
Takeda Pharmaceutical Company Limited (TAK) had Raw Materials of JPY 341.64 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:RawMaterials · last filed 2025-06-25
- 2025-03-31: Raw Materials 341.64B JPY.
- 2024-03-31: Raw Materials 337.61B JPY.
- 2023-03-31: Raw Materials 280.91B JPY.
- 2022-03-31: Raw Materials 224.98B JPY.
| Period end | Raw Materials |
|---|---|
| 2025-03-31 | 341.64B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 337.61B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 280.91B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 224.98B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 149.56B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 157.78B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 161.59B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 63.55B JPY 20-F · filed 2019-06-27 |